• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Greenovation Biotech - Articles and news items

moss-agal

Greenovation to start Phase I clinical trial for moss-aGal

Industry news / 16 September 2015 / Victoria White

Moss-aGal, a recombinant form of human alpha galactosidase, is the world´s first moss-produced drug candidate…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +